BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30867307)

  • 1. Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of
    Juno JA; Wragg KM; Kristensen AB; Lee WS; Selva KJ; van der Sluis RM; Kelleher AD; Bavinton BR; Grulich AE; Lewin SR; Kent SJ; Parsons MS
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
    Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
    Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
    Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S
    Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F
    J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
    Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.
    Lehner T; Wang Y; Cranage M; Tao L; Mitchell E; Bravery C; Doyle C; Pratt K; Hall G; Dennis M; Villinger L; Bergmeier L
    Immunology; 2000 Apr; 99(4):569-77. PubMed ID: 10792505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.
    Tanaka R; Takahashi Y; Kodama A; Saito M; Ansari AA; Tanaka Y
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1147-54. PubMed ID: 20854204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes.
    Wang J; Guan E; Roderiquez G; Norcross MA
    J Immunol; 1999 Dec; 163(11):5763-9. PubMed ID: 10570258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of R5-tropic HIV type-1 replication in CD4⁺ natural killer T cells by γδ T lymphocytes.
    Omi K; Shimizu M; Watanabe E; Matsumura J; Takaku C; Shinya E; Takahashi H
    Immunology; 2014 Apr; 141(4):596-608. PubMed ID: 24266436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.
    Marino AP; da Silva A; dos Santos P; Pinto LM; Gazzinelli RT; Teixeira MM; Lannes-Vieira J
    Circulation; 2004 Sep; 110(11):1443-9. PubMed ID: 15337689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection.
    Bogers WM; Bergmeier LA; Ma J; Oostermeijer H; Wang Y; Kelly CG; Ten Haaft P; Singh M; Heeney JL; Lehner T
    AIDS; 2004 Jan; 18(1):25-36. PubMed ID: 15090826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women.
    Wang Y; Tao L; Mitchell E; Bravery C; Berlingieri P; Armstrong P; Vaughan R; Underwood J; Lehner T
    Nat Med; 1999 Sep; 5(9):1004-9. PubMed ID: 10470076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE).
    Moss RB; Giermakowska WK; Diveley JP; Savary JR; Wallace MR; Maigetter RZ; Jensen FC; Carlo DJ
    J Hum Virol; 2000; 3(1):44-9. PubMed ID: 10774806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in Africa.
    Kalinkovich A; Weisman Z; Leng Q; Borkow G; Stein M; Greenberg Z; Zlotnikov S; Eitan S; Bentwich Z
    J Hum Virol; 1999; 2(5):283-9. PubMed ID: 10551734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
    Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
    AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.